|
|
|
|
|
6. Public's perspective on COVID-19 adenovirus vector vaccines after thrombosis with thrombocytopenia syndrome (TTS) reports and associated regulatory actions - a cross-sectional study in six EU member statesCaroline Buhl, Ramune Jacobsen, Anna Birna Almarsdóttir, Shahab Abtahi, Armin Andersen, Elena Deligianni, Foteini Dermiki-Gkana, Christos Kontogiorgis, Mitja Kos, Nanča Čebron Lipovec, 2024, original scientific article Keywords: public perception, COVID-19 vaccines, thrombosis with thrombocytopaenia syndrome (TTS), SARS-CoV-2 adenovirus vector vaccines, national health policies, risk awareness Full text (file, 608,88 KB) This document has more files! More... |
7. Impact of regulatory risk communication on thrombosis with thrombocytopenia syndrome for COVID-19 adenovirus vector vaccines on European Healthcare ProfessionalsElla van Vliet, Nanča Čebron Lipovec, Marloes van der Goot, Shahab Abtahi, Inês Ribeiro-Vaz, Elita Poplavska, Foteini Dermiki-Gkana, Chara Oikonomou, Elena Deligianni, Mitja Kos, 2024, original scientific article Keywords: COVID-19 vaccines, healthcare professionals, regulatory actions, risk communication, SARS- CoV-2 adenovirus vector vaccines, thrombosis with thrombocytopenia syndrome Full text (file, 386,89 KB) This document has more files! More... |
|
|
|